Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose lithium in long COVID
NCT05618587Phase 2Completed
- Sponsor
- University at Buffalo
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium in post-COVID-19 condition (PCC), sponsored by University at Buffalo. Started Nov 2022; status: completed.
02
Drugs
lithium
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT05618587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05618587.